Status:
UNKNOWN
Biomarkers for Diagnosis, Prognosis, and Targeted Therapy After Heart Transplantation
Lead Sponsor:
Helsinki University Central Hospital
Conditions:
Heart Transplant Rejection
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this prospective observational single center study is to investigate donor-derived cell-free DNA (ddcfDNA), peripheral blood platelet mRNA, peripheral blood extracellular vesicle mRNA...
Eligibility Criteria
Inclusion
- patient age \> 18 years
- heart transplant recipient
- has signed informed consent
Exclusion
- foreign residency
- no signed informed consent collected
Key Trial Info
Start Date :
January 22 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06064123
Start Date
January 22 2019
End Date
December 31 2025
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsinki University Hospital
Helsinki, Uusimaa, Finland, 00029